More NewsRead More
Biodel to Present at Two Upcoming Investor Conferences
June 18, 2015
Biodel to Present Data on Concentrated Ultra-Rapid-Acting/Basal Insulin and Glucagon at the 75th American Diabetes Association Scientific Sessions
May 28, 2015
Biodel Announces Phase 2b Clinical Trial Initiation of BIOD-531, the Company's Concentrated, Ultra-Rapid-Acting, Prandial/Basal Combination Insulin Candidate
May 21, 2015
Recent Developments in the Pharma Sector: Complementary Research on AVEO Oncology, Capnia, 22nd Century Group, Biodel, and Discovery Laboratories
April 24, 2015
from PR Newswire
Biodel Announces Pricing of Public Offering of Common Stock
April 15, 2015
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here